22 May 2020 – Serological tests not to be used for the diagnosis of COVID-19

Type of Intervention: Guidance
Sectors Involved: Health
Intervention Categories: Research and development
Level of Jurisdiction: National
Lead People/Agency: Ministry of Health

Overview: Researchers and experts from Vilnius University (VU) and Santara Clinics conducted a biomedical study and concluded that serological tests from both manufacturers, both quantitative (IgG / IgA) and rapid (IgG / IgM), should not be used for acute coronavirus infection (COVID). 19) to diagnose. In other words, they are not suitable for early diagnosis of COVID-19 because the sensitivity of the tests is too low. According to the researchers, serological tests should be used to check whether a person has had a coronavirus infection, ie to detect so-called seroconversion.
Full details here: http://sam.lrv.lt/lt/naujienos/serologiniai-testai-tyrimas-parode-kad-ankstyvai-diagnostikai-jie-nenaudotini

Type of Justification: Advice of EXTERNAL expert advisor or advisory committee, Scientific Evidence (e.g. academic paper, report)
Source of Evidence or Justification: National – academic
Evidence/Justification: The Ministry of Health has ordered a scientific trial. It has been conducted by the Centre of Life Sciences of Vilnius University and clinics of Santara.